Reaction

Pneumonia Pseudomonal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,500 reports · 94 co-occurring drugs

As of the last recalculation, Pneumonia Pseudomonal appears in 1,500 FAERS reports alongside 94 co-occurring drug terms. The strongest observed disproportionality signal is TOBRAMYCIN SOLUTION (PRR 43.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Tobramycin Solution	37	43.8	43.9
Tobramycin Sulfate	38	43.7	43.8
Tobramycin	69	41.7	41.8
Ganciclovir	25	34.5	34.5
Ganciclovir Sodium	25	33.3	33.4
Bendamustine Hcl	35	32.0	32.1
Daspone	21	30.3	30.4
Dapsone Gel, 5%	21	30.3	30.4
Dornase Alfa	41	29.8	29.9
Dapsone	21	27.7	27.7
Remdesivir	26	27.5	27.6
Polatuzumab Vedotin	19	27.3	27.4
Human Immunoglobulin G	39	26.9	27.0
Valganciclovir Hydrochloride Powder,	23	26.6	26.6
Meropenem	58	26.0	26.1
Tacrolimus Ointment 0.1%	203	26.0	26.0
Tacrolimus Extended-Release Capsules	203	25.9	26.0
Posaconazole Delayed-Release	20	25.6	25.6
Cefepime Hydrochloride	29	25.4	25.5
Mycophenilic Acid	37	25.4	25.4
Basiliximab	21	25.1	25.2
Baricitinib	17	24.7	24.8
Amphotericin B	22	24.7	24.8
Voriconazole Injection	37	24.2	24.3
Valganciclovir	32	24.0	24.1
Valganciclovir Hydrochloride	32	24.0	24.1
Elexacaftor, Tezacaftor, And Ivacaftor	21	23.7	23.7
Tacrolimus	223	23.0	23.1
Ivacaftor	13	22.9	22.9
Axicabtagene Ciloleucel	16	22.7	22.8
Piperacillin Sodium,Tazobactam Sodium	42	22.6	22.6
Cefepime	22	21.6	21.6
Micafungin Sodium	13	21.5	21.5
Bendamustine Hydrochloride	18	21.1	21.1
Voriconazole	41	19.2	19.3
Posaconazole	22	19.1	19.1
Daptomycin	12	18.2	18.2
Lumacaftor And Ivacaftor	11	17.9	18.0
Azithromycin	50	17.8	17.8
Mycophenolic Acid	40	17.8	17.8
Sirolimus	17	17.7	17.7
Everolimus Tablets	21	17.6	17.6
Azithromycin Monohydrate	50	17.2	17.2
Fludarabine Phosphate	45	16.3	16.4
Tofacitinib Citrate	15	16.0	16.0
Piperacillin Sodium And Tazobactam Sodium	22	15.8	15.8
Amikacin	19	15.6	15.7
Piperacillin And Tazobactam	14	15.3	15.3
Azithromycin Dihydrate	60	14.7	14.8
Mycophenolate Mofetil	132	14.7	14.7
Mycophenolate Mofetil Hydrochloride	132	14.7	14.7
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	21	14.4	14.4
Naproxen Sodium, Pseudoephedrine Hydrochloride	21	14.3	14.4
Guaifenesin	30	13.9	13.9
Umeclidinium	8	12.5	12.5
Melphalan	20	12.4	12.4
Itraconazole	10	12.0	12.0
Melphalan Hydrochloride	20	11.2	11.2
Tiotropium Bromide Inhalation Spray	9	11.2	11.2
Benralizumab	15	10.5	10.5
Anti-Thymocyte Globulin (Rabbit)	6	10.4	10.4
Thiotepa	7	10.2	10.2
Filgrastim	27	10.1	10.1
Sodium Chloride Tablet	50	9.7	9.7
Sodium Chloride Tablets	50	9.7	9.7
Levofloxacin	41	9.7	9.7
Levofloxacin In 5% Dextrose	41	9.7	9.7
Sodium Chloride	53	9.6	9.6
Azelastine	12	9.3	9.3
Ravulizumab	9	9.3	9.3
Anakinra	11	9.3	9.3
Adrenalinum	27	9.2	9.2
Ifosfamide	14	9.1	9.1
Etoposide	46	8.9	8.9
Pancrelipase	24	8.8	8.8
Cyclophosphamide Injection, Solution	102	8.5	8.5
Cyclophosphamide	102	8.5	8.5
Cyclophosphamide For Injection	102	8.5	8.5
Cytarabine	35	8.3	8.3
Valproic Acid	18	8.0	8.0
Linezolid	17	8.0	8.0
Oseltamivir	4	7.0	7.0
Ibrutinib	38	6.7	6.7
Doxorubicin	41	6.5	6.5
Brivaracetam	4	6.2	6.2
Ruxolitinib	31	6.1	6.1
Carboplatin	52	5.8	5.9
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	17	5.7	5.8
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	5.4	5.4
Budesonide, Glycopyrrolate, And Formoterol Fumarate	4	5.3	5.3
Venetoclax	21	4.8	4.8
Sarilumab	9	4.8	4.8
Carfilzomib	9	4.4	4.4
Pomalidomide	17	2.3	2.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.